Victor Dzau is President of National Academy of Medicine, vice chair of National Research Council, chancellor emeritus and Distinguished Professor of Duke University. Previously, he was chairman of medicine at Harvard and Stanford Universities. He is recognized globally for a highly decorated career as a physician scientist, and leader. His research laid the foundation for lifesaving drugs known as ACE inhibitors. He pioneered gene therapy for vascular disease and is now studying cardiac regeneration. Dr. Dzau has served as the chair of the NHLBI Progenitor Cell and Translational Consortia. Dzau has devoted his career to scientific innovation, global health, and equity. At the NAM, he has launched important initiatives on the biomedical research enterprise, global health risk framework, gene editing, and climate change. Dzau cochaired the G20 Scientific Panel on Global Health Security and was an advisor to the G7 Health Task Force.